These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6433771)

  • 1. Effect of methods of platelet resuspension on stored platelets.
    Kiraly T; Bernier S; Kakaiya RM; Cable RG
    Ann Clin Lab Sci; 1984; 14(5):366-70. PubMed ID: 6433771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reevaluation of the resting time period when preparing whole blood-derived platelet concentrates with the platelet-rich plasma method.
    Moroff G; Kline L; Dabay M; Hunter S; Johnson A; McNeil D; Nixon J; Sawyer S; Taylor H; Whitley P; Wahab F; Murphy S
    Transfusion; 2006 Apr; 46(4):572-7. PubMed ID: 16584433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation of the INTERCEPT Blood System for Platelets into routine blood bank manufacturing procedures: evaluation of apheresis platelets.
    Janetzko K; Lin L; Eichler H; Mayaudon V; Flament J; Klüter H
    Vox Sang; 2004 May; 86(4):239-45. PubMed ID: 15144528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of the quality of hemoderivatives obtained using a buffy-coat extraction system with a top-and-bottom technique (Optipress II)].
    Hurtado C; Bonanad S; Soler MA; Mirabet V; Blasco I; Planelles MD; de Miguel A
    Sangre (Barc); 1999 Oct; 44(5):319-26. PubMed ID: 10618907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Room temperature storage and cryopreservation of canine platelet concentrates.
    Allyson K; Abrams-Ogg AC; Johnstone IB
    Am J Vet Res; 1997 Nov; 58(11):1338-47. PubMed ID: 9361903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality analysis of blood components obtained by automated buffy-coat layer removal with a top & bottom system (Optipress (R)II).
    Hurtado C; Bonanad S; Soler Mf; Mirabet V; Blasco I; Planelles Mf; De Miguel A
    Haematologica; 2000 Apr; 85(4):390-5. PubMed ID: 10756365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelets stored in a new-generation container differences between plasma and platelet additive solution II.
    de Wildt-Eggen J; Schrijver JG; Smid WM; Joie M; Bollinne V; Bins M
    Vox Sang; 1998; 75(3):218-23. PubMed ID: 9852410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interruption of agitation of platelet concentrates: effects on in vitro parameters.
    van der Meer PF; Gulliksson H; Aubuchon JP; Prowse C; Richter E; de Wildt-Eggen J;
    Vox Sang; 2005 May; 88(4):227-34. PubMed ID: 15877643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro evaluation of COM.TEC apheresis platelet concentrates using a preparation set and pathogen inactivation over a storage period of five days.
    Moog R; Fröhlich A; Mayaudon V; Lin L
    J Clin Apher; 2004; 19(4):185-91. PubMed ID: 15597347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Storage of buffy-coat-derived platelets in additive solutions at 4 degrees C and 22 degrees C: flow cytometry analysis of platelet glycoprotein expression.
    Sandgren P; Hansson M; Gulliksson H; Shanwell A
    Vox Sang; 2007 Jul; 93(1):27-36. PubMed ID: 17547562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes in platelet concentrates from dogs due to storage. I. Platelet count in in vitro function].
    Klein A; Adamik A; Mischke R
    Berl Munch Tierarztl Wochenschr; 1999; 112(6-7):243-53. PubMed ID: 10472723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interruption of agitation of platelet concentrates: a multicenter in vitro study by the BEST Collaborative on the effects of shipping platelets.
    Dumont LJ; Gulliksson H; van der Meer PF; Murphy S; Nixon JG; de Wildt-Eggen J; Vandenbroeke T; Aubuchon JP
    Transfusion; 2007 Sep; 47(9):1666-73. PubMed ID: 17725732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of interruption of agitation on in vitro measures of platelet concentrates in additive solution.
    van der Meer PF; Liefting LA; Pietersz RN
    Transfusion; 2007 Jun; 47(6):955-9. PubMed ID: 17524082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of a novel viscous platelet additive solution and plasma: preparation and in vitro storage parameters of buffy-coat-derived platelet concentrates.
    Zhang JG; Carter CJ; Devine DV; Scammell K; Weiss S; Gyongyossy-Issa MI
    Vox Sang; 2008 May; 94(4):299-305. PubMed ID: 18179681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet capacity of various platelet pooling systems for buffy coat-derived platelet concentrates.
    Dijkstra-Tiekstra MJ; Kuipers W; Setroikromo AC; de Wildt-Eggen J
    Transfusion; 2008 Oct; 48(10):2114-21. PubMed ID: 18647365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Buffy-coat platelet variables and metabolism during storage in additive solutions or plasma.
    Zhang JG; Carter CJ; Culibrk B; Devine DV; Levin E; Scammell K; Weiss S; Gyongyossy-Issa MI
    Transfusion; 2008 May; 48(5):847-56. PubMed ID: 18298601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of blood components prepared from whole-blood donations after a 24-hour hold with the platelet-rich plasma method.
    Thibault L; Beauséjour A; de Grandmont MJ; Lemieux R; Leblanc JF
    Transfusion; 2006 Aug; 46(8):1292-9. PubMed ID: 16934062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Quality control of platelet concentrates. Functional assessment of stored platelets in vitro].
    Groh J; Storck K; Kratzer MA
    Anaesthesist; 1993 Dec; 42(12):847-55. PubMed ID: 8304580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of different hold time before addition of platelet additive solution on the in vitro quality of apheresis platelets.
    Ringwald J; Haager B; Krex D; Zimmermann R; Strasser E; Antoon M; De Schrijver E; Eckstein R
    Transfusion; 2006 Jun; 46(6):942-8. PubMed ID: 16734810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintenance of platelet in vitro properties during 7-day storage in M-sol with a 30-hour interruption of agitation.
    Wagner SJ; Myrup A; Awatefe H; Thompson-Montgomery D; Hirayama J; Skripchenko A
    Transfusion; 2008 Dec; 48(12):2501-607. PubMed ID: 18764828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.